Abstract Besides different risk profiles for cardiovascular events in men and women, several studies reported gender differences in mortality after acute myocardial infarction (AMI). As infarct size has been shown to correlate with mortality, it is widely accepted as surrogate marker for clinical outcome. Currently, cardiovascular imaging studies covering the issue of gender differences are rare. As magnetic resonance scar characterization parameters are emerging as additional prognostic factors after acute myocardial infarction, we sought to evaluate gender differences in CMR infarct characteristics in patients after acute myocardial infarction. We prospectively analyzed patients (n = 448) with AMI and primary angioplasty, who underwent contrast enhanced cardiac magnetic resonance (CMR) imaging on a 1.5 T scanner in median 5 [Galatius-Jensen et al. in BMJ 313(7050):137-140, (1996), Burns et al. in J Am Coll Cardiol 39(1):30-36, (2002)] days after the acute event. CMR scar size was measured 15 min after gadolinium injection. In addition presence and extent of microvascular obstruction (MVO) was assessed. A matched pair analysis was performed in order to exclude confounding by gender related co-morbidities and gender differences in established clinical risk factors. Matching process according to clinical risk defined by GRACE score resulted in 93 mixed gender couples. Women were significantly older than men (64.4 ± 11.9 vs. 60.5 ± 12.3, p = 0.03) and presented with a significantly better ejection fraction before angioplasty (48.9 ± 8.4 vs. 46.2 ± 8.9, p = 0.04). Infarct size did not differ significantly between women and men (13.5 ± 10.7 vs. 15.1 ± 11.8, p = 0.32). Size of MVO was significantly smaller in women than in men (0.48 ± 1.3 vs. 1.2 ± 3.0, p = 0.03). Comparing scar characterization between women and men with similar risk profiles revealed no gender differences in scar size. Size of MVO, however, was significantly smaller in women and might reflect better cardioprotective mechanisms in women. Whether these changes have prognostic implications has to be tested on a larger patient population.
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Background
Women with acute myocardial infarction show a higher risk profile compared to men [1, 2] . Besides different risk profiles for cardiovascular events in men and women, several studies reported controversial data on gender differences in mortality after acute myocardial infarction. A worse short-term prognosis after AMI in female than male patients has been linked to differences in risk profile and treatment at the time of the event [3] . The few studies with longterm follow-up have mostly reported no differences in longterm prognosis between men and women [4, 5] . As infarct size has been shown to closely correlate with mortality [6, 7] , it is widely accepted as a surrogate marker for clinical outcome [8, 9] . Despite the advances of modern reperfusion strategies, residual necrosis remains a problem in patients suffering from myocardial infarction leading to significant morbidity and mortality during subsequent years. Noninvasive assessment of infarct size is a useful clinical tool allowing for risk stratification and guiding further medical treatment [10, 11] . Currently, cardiovascular imaging studies covering the issue of gender differences are rare. Reports on gender differences of infarct characterization are limited and so far there are only few data available for single photon emission computed tomography (SPECT) [12] and CMR [13, 14] . As magnetic resonance scar characterization parameters are emerging as additional prognostic factors after acute myocardial infarction, we sought to evaluate gender differences in CMR infarct characteristics in patients with similar clinical risk profiles after acute myocardial infarction.
Methods

Study population and design
All patients with acute ST-segment elevation (STEMI) or non-ST-segment elevation (NSTEMI) myocardial infarction who underwent contrast enhanced cardiac magnetic resonance imaging after primary angioplasty in the two participating hospitals between April 1st 2002 and September 1st, 2011 were included in this study. Patients were diagnosed with STEMI, if they presented with chest pain lasting at least 20 min associated with electrocardiographic (ECG) changes (ST-segment elevation, new onset left bundle branch block) and if the onset of symptoms was less than 24 h before PCI. ST-segment elevation had to measure at least 0.1 mV in C2 limb leads or at least 0.2 mV in C2 precordial leads. Patients were diagnosed with NSTEMI if they presented with chest pain in the absence of persistent ST-segment elevation on the presenting 12-lead electrocardiogram and if they had elevated troponin levels and an onset of symptoms of less than 72 h before PCI [15] . Patients with prior myocardial infarction based on clinical history and on CMR images acquired in this study were excluded, to ensure that CMR findings displayed acute myocardial injury. Further exclusion criteria were known contraindications to CMR study such as implanted pacemakers, defibrillators, claustrophobia, or metallic intracranial implants and contraindications to the use of contrast agent such as renal insufficiency (GFR \50 ml/min) or known allergy to gadolinium based contrast media. All patients gave written informed consent to the investigation.
All patients were treated with percutaneous coronary intervention (PCI) of the infarct related artery immediately after hospital admission. Contrast enhanced cardiac CMR was scheduled to take place 5-7 days after PCI.
Classical risk factors and those necessary for calculation of the GRACE risk score were documented. Hypertension, hypercholesterolemia, diabetes, and a family history of premature coronary artery disease were defined according to current guidelines. Patients' individual clinical and periprocedural risk was assessed by calculating global registry of acute coronary events (GRACE) risk score [16] , which was created at the Center for Outcomes Research of the University of Massachusetts in a large multinational registry of patients with acute coronary syndromes (ACS) [16] . The GRACE score includes age, heart rate, systolic blood pressure, creatinine, Killip class, cardiac arrest at admission, elevated cardiac markers and ST segment deviation with follow-up at 6 months [16] . The study protocol was approved by the institutional ethics committee responsible for both participating centers.
During the study period 481 patients (female: 103, male: 378) with AMI and primary angioplasty underwent contrast enhanced MR imaging in median 5 days [4, 6] after the event. 5 women and 28 men were excluded because of prior myocardial infarction leaving 98 women and 350 men for matching.
Magnetic resonance imaging
Contrast-enhanced magnetic resonance imaging was performed on 1.5-T systems (Philips Achieva, Philips, Best, the Netherlands and Siemens Sonata and Avanto, both Siemens Medical Solutions, Erlangen, Germany) equipped with a dedicated cardiac phased-array surface coil. For image acquisition, patients were positioned in a supine position and images were acquired at repeated end-expiratory breath hold with ECG gating. The infarct scar was assessed 15 min after injection of 0.2 mmol/kg body weight of dimeglumingadopentetat (Magnevist, Bayer HealthCare Pharmaceuticals, Berlin, Germany or Magnograf, Marotrast GmbH, Jena, Germany) on T1-weighted inversion-recovery turbo fast low angle shot sequence (slice thickness 8 mm; TR 4.0 ms; TE 1.5 ms; image matrix 175 9 256; flip angle 30°). Since October 2006, quantification of area at risk was performed additionally using a T2-weighted, fat-suppressed, blackblood, turbospin echo sequence (slice thickness 8 mm; repetition time (TR) 2 RR-intervals; echo time (TE) 99 ms; image matrix 145 9 192) prior to contrast injection. For both acquisitions, contiguous short-axis slices of the left ventricle from base to apex as well as 2-and 4-chamber views of the left ventricle were acquired. The inversion time (TI) was individually adjusted to null normal myocardium (typical values range from 230 to 300 ms).
For infarct size quantification endocardial and epicardial contours were manually traced on each of the short axis slices by an experienced reader. The defect size was then calculated automatically by comparison with a manually marked region of healthy remote myocardium and was expressed as percentage of total LV myocardial volume [17] . Area at risk was defined as a region of hyperintense myocardium with signal intensity above 2 standard deviations of healthy remote myocardium [18] . Infarcted, hyperenhanced myocardium was calculated based on the same algorithm using a threshold of 3 standard deviations above healthy remote myocardium for total infarct size best matching the results of manual delineation and 6 standard deviations above remote for infarct core which correlated better with outcome in a previous analysis [19] . In consensus with previous studies, myocardial enhancement required at least 10 adjacent myocardial pixels to have, by definition, increased signal intensity [20] . MVO was defined as an area of hypoenhancement within the infarcted myocardium and was included in the infarct size calculation. As valid automated detection of MVO is not established, the size of MVO was quantified by manually delineating its contours within the infarcted myocardium. The MVO analyzed in this study has been described as late [21] or persistent [22] MVO in other studies. Salvage area in CMR was defined as the difference between T2 defect and total infarct size assessed by late enhancement imaging. Salvage area, infarct size, including size of infarct core, and MVO were expressed as percentage of total LV myocardial mass [17] (Fig. 1) . Analysis was performed using software developed in house and validated against a commercially available software package.
Statistical analysis
Categorical variables were expressed as frequencies and percentages, continuous variables were expressed as mean ± standard deviation. Continuous data were compared with the use of two-tailed t test. Categorical data were compared with the use of Fisher's exact test. A matched pair analysis of men and women was performed in order to exclude confounding by gender related co-morbidities and gender differences in established clinical risk factors using a random mode computerized matching process according to clinical risk defined by GRACE score. Subjects in the male and female group were matched according to their clinical risk using the GRACE score as the best clinical risk predictor. The statistical package R version 2.10.1 (R-Development-Core-Team, Vienna) [23] including the package Design [24] was used for statistical analysis. Statistical significance was accepted for twotailed p-values \0.05.
Results
Study population, clinical and infarct characteristics
Matching resulted in the formation of 93 mixed gender couples. Female patients were significantly older than male Left: original image, Right: Semiautomated quantification, Microvascular obstruction (magenta) was delineated manually, infarct core (red) and total infarct size (red and yellow combinded) were automatically quantified using 6 respectively 3 SD above remote healthy myocardium, LGE late gadolinium enhancement, MVO microvascular obstruction. The blue semicircle outline delineates the area for reference healthy remote myocardium 13.4 ± 15 % LV, p = 0.76). Infarct size later than 4 months after infarction was assessed in 30 women and 31 men. In those patients infarct size was 14.4 ± 7.8 % LV in women and 17.0 ± 10.6 % LV in men with no significant difference between the two groups (p = 0.28). A detailed summary of CMR results is provided in Table 3 .
Discussion
Only few studies to evaluate gender differences in CMR imaging characteristics of AMI exist [13, 14] . Women largely share similar cardiovascular risk factors for CHD with men however, women with ischemic heart disease and cardiovascular events have less coronary atherosclerosis than men, even though they are older, as seen in this study. Moreover, women have a higher prevalence of cardiovascular risk factors such as diabetes, arterial hypertension, or hypercholesterolemia than men [25, 26] but still a lower incidence of STEMI in women exists [27] . As clinical risk profiles have been found to differ in various aspects between men and women, we sought to evaluate women and men of similar cardiovascular risk as expressed by means of GRACE score, who received essentially identical therapy consisting of timely reperfusion therapy via percutaneous coronary intervention. The main findings of the matched pair analysis can be summarized as follows: (1) Infarct size does not show significant gender differences in women and men of similar clinical risk profile. (2) The size of microvascular obstruction, however, is significantly smaller in women.
Contrast enhanced CMR is a proven method for the detection and quantification of myocardial scars [28] and multiple studies found a good correlation of scar extent by CMR with SPECT [11, 29] in acute myocardial infarction. In addition, Wagner et al. [30] as well as Ibrahim et al. [31] showed that CMR systematically detects subendocardial infarcts that are missed by SPECT as CMR benefits from a higher spatial resolution and is less prone to attenuation artifacts. Imaging studies about gender differences in infarct characteristics are currently rare. In a Tc99 m -sestamibi SPECT study including 202 women and 561 men with AMI after primary PCI, Mehilli et al. [12] found a significantly smaller infarct size and significantly higher myocardial salvage in women. These findings go in line with a CMR study by Canali and coworkers, yet in a smaller subset of patients with acute STEMI [13] . Another CMR study in a comparable population by Eitel et al. [14] could not confirm the finding of smaller infarct size and greater myocardial salvage in women. In difference to the previously mentioned studies, we aimed at exclusion of confounding by differences in co-morbidities by correcting for pre-test risk expressed by GRACE risk score. Moreover, by matching men and women, we tried to overcome influences of a numeric gender disparity because of a clearly lower incidence of AMI in women [12, 32, 33] . Our smaller sample size and the fact that we additionally performed a matched pair analysis might explain why our data do not support the finding of different infarct size in gender. In line with the study of Dall'Armellina et al., data of a follow up study in a small subset of our study population 6 months after the index event are suggestive that no gender difference exists in the size of healed infarction, too [34] . Contrary results have been found concerning the influence of gender on size of MVO [13, 14] . As previously The phenomenon of no-reflow or microvascular obstruction [35, 36] is a consequence of several molecular mechanisms that are influenced by estrogen. Metabolic stress-induced Ca 2? loading and poor hypoxia tolerance of cardiac myocytes, as well as endothelin-mediated vasoconstriction during ischemia are such pathophysiologic pathways contributing to the formation of MVO.
Reperfusion leads to an abrupt metabolic stress-induced Ca 2? loading in myocardial cells causing cell death [37, 38] . 17-ß-estradiol, however, can attenuate this process by directly protecting cardiomyocytes against intracellular Ca 2? loading via an estrogen receptor mediated mechanism [39] . Both males and females have estrogen receptors in the vascular endothelium, smooth muscle, and myocardium, but receptor numbers may be higher in females because estrogen induces their expression [40] . The no-reflow phenomenon at the time of reperfusion ultimately results in myocyte cell death as a consequence of the failure to reperfuse potentially viable though severely ischemic myocytes [36] . In experimental studies on mice, female myocytes have been shown to tolerate hypoxemia better than males [41] , in part, due to a femalespecific lower activation of signaling pathways controlling cell cycle progression and apoptosis under induced hypoxia [42] . Circulating levels of endothelin, a potent and long-acting vasoconstrictor, are low in normal individuals but increased during ischemia, with a further increase during reperfusion [35, 43] . Endothelin-mediated vasoconstriction, neutrophil plugging, and microvascular permeability play a role in the pathogenesis of MVO [35] . The significant reduction of MVO and infarct size in a canine model after the administration of an endothelin A-receptor antagonist after 90 min of coronary occlusion supports this concept [44] . Oestrogens cause vasodilation in the cardiovascular system by inhibiting the endothelin-1 production and via several other mechanisms [45] . This might explain why in our study women displayed significantly smaller microvascular obstructions then men. Differences in clinical risk were largely eliminated by the matched pair design of this study. In addition, the prevalence of single-or multi-vessel coronary artery disease was equally distributed between men and women and therefore, the effect of affected vessels other than the coronary artery supplying the infarcted myocardial segment that could have influenced the size of MVO by contributing to a more diffuse myocardial disease or subclinical ischemia, probably is only minor. However, men do have a worse left ventricular function at the time of intervention and finally it remains unclear whether this is indicative of a larger area at risk in men or a result of worse hypoxia intolerance. Since all other parameters including the quantification of the area at risk by T2 imaging show no gender differences we believe that a difference in hypoxia intolerance best explains the findings of this study.
In previous studies evaluating the prognostic significance of CMR infarct characteristics, the presence and extent of MVO displayed an incremental prognostic value above traditional prognostic markers with a prognostic sensitivity and specificity superior to total infarct size [21, 46, 47] . Thus, the presence and extent of MVO might indicate a worse ischemia tolerance, which might result in increased mortality.
Our finding of significantly smaller size of MVO in women and the gender differences in the underlying pathophysiologic mechanisms could translate into a better ischemia tolerance in female patients with myocardial infarction and an effective longer timeframe for successful reperfusion therapy resulting in a greater myocardial salvage. This would explain why the extent of the salvaged myocardium assessed by SPECT in the study of Mehilli et al. as well as in the CMR study of Canali et al. was gender dependent and higher in women [12, 13] .
A limitation of this study is the relatively small number of patients included in the matched pair analysis that did not allow for a multivariate analysis and further prognostic evaluation of gender differences in myocardial infarction imaging characteristics. Moreover, the analysis of infarct characteristics in women with respect to their menopausal status, data that was not collected in this study, would be important to distinguish ischemic changes to the myocardium relative to circulating estrogen levels. Due to the time interval of only 5-7 days between myocardial infarction and CMR scan the infarcted myocardium is still in the healing process and the infarct size measured by CMR may not be identical to the size of the completely healed infarction.
Conclusions
In conclusion, comparing scar characterization on pre discharge contrast-enhanced cardiac magnetic resonance imaging between women and men with similar risk profiles revealed no gender differences in scar size. However, MVO is significantly smaller in women and might reflect better cardioprotective mechanisms in women. Gender related differences in myocardial response to ischemic injury have to be examined in a larger patient population. The prognostic value of these findings and the clinical effect of a sex-adjusted adjunctive therapy for the prevention of adverse remodeling of infarcted myocardium, need to be further evaluated.
